These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) mice. Suzuki R; Tobe K; Aoyama M; Inoue A; Sakamoto K; Yamauchi T; Kamon J; Kubota N; Terauchi Y; Yoshimatsu H; Matsuhisa M; Nagasaka S; Ogata H; Tokuyama K; Nagai R; Kadowaki T J Biol Chem; 2004 Jun; 279(24):25039-49. PubMed ID: 15028732 [TBL] [Abstract][Full Text] [Related]
11. Elimination of negative feedback control mechanisms along the insulin signaling pathway improves beta-cell function under stress. Gurevitch D; Boura-Halfon S; Isaac R; Shahaf G; Alberstein M; Ronen D; Lewis EC; Zick Y Diabetes; 2010 Sep; 59(9):2188-97. PubMed ID: 20547979 [TBL] [Abstract][Full Text] [Related]
12. Roles of Insulin Receptor Substrates (IRS) in renal function and renal hemodynamics. Hashimoto S; Maoka T; Kawata T; Mochizuki T; Koike T; Shigematsu T PLoS One; 2020; 15(12):e0242332. PubMed ID: 33270683 [TBL] [Abstract][Full Text] [Related]
13. miR-135a targets IRS2 and regulates insulin signaling and glucose uptake in the diabetic gastrocnemius skeletal muscle. Agarwal P; Srivastava R; Srivastava AK; Ali S; Datta M Biochim Biophys Acta; 2013 Aug; 1832(8):1294-303. PubMed ID: 23579070 [TBL] [Abstract][Full Text] [Related]
15. IRS2 signaling in LepR-b neurons suppresses FoxO1 to control energy balance independently of leptin action. Sadagurski M; Leshan RL; Patterson C; Rozzo A; Kuznetsova A; Skorupski J; Jones JC; Depinho RA; Myers MG; White MF Cell Metab; 2012 May; 15(5):703-12. PubMed ID: 22560222 [TBL] [Abstract][Full Text] [Related]
16. Insulin receptor substrate 2 (IRS2)-deficient mice show sensorineural hearing loss that is delayed by concomitant protein tyrosine phosphatase 1B (PTP1B) loss of function. Murillo-Cuesta S; Camarero G; González-Rodríguez A; De La Rosa LR; Burks DJ; Avendaño C; Valverde AM; Varela-Nieto I Mol Med; 2012 Mar; 18(1):260-9. PubMed ID: 22160220 [TBL] [Abstract][Full Text] [Related]
17. IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes. Santamaria B; Marquez E; Lay A; Carew RM; González-Rodríguez Á; Welsh GI; Ni L; Hale LJ; Ortiz A; Saleem MA; Brazil DP; Coward RJ; Valverde ÁM Biochim Biophys Acta; 2015 Dec; 1853(12):3224-34. PubMed ID: 26384875 [TBL] [Abstract][Full Text] [Related]
18. Autophagy plays beneficial effect on diabetic encephalopathy in type 2 diabetes: studies in vivo and in vitro. Jing YH; Zhang L; Gao LP; Qi CC; Lv DD; Song YF; Yin J; Wang DG Neuro Endocrinol Lett; 2017 Feb; 38(1):27-37. PubMed ID: 28456145 [TBL] [Abstract][Full Text] [Related]
19. Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice. Kushner JA; Haj FG; Klaman LD; Dow MA; Kahn BB; Neel BG; White MF Diabetes; 2004 Jan; 53(1):61-6. PubMed ID: 14693698 [TBL] [Abstract][Full Text] [Related]
20. Insulin-receptor substrate-2 (irs-2) is required for maintaining glucokinase and glucokinase regulatory protein expression in mouse liver. Roncero I; Alvarez E; Acosta C; Sanz C; Barrio P; Hurtado-Carneiro V; Burks D; Blázquez E PLoS One; 2013; 8(4):e58797. PubMed ID: 23560040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]